[HTML][HTML] The p53 pathway in glioblastoma

Y Zhang, C Dube, M Gibert Jr, N Cruickshanks, B Wang… - Cancers, 2018 - mdpi.com
The tumor suppressor and transcription factor p53 plays critical roles in tumor prevention by
orchestrating a wide variety of cellular responses, including damaged cell apoptosis …

When mutants gain new powers: news from the mutant p53 field

R Brosh, V Rotter - Nature reviews cancer, 2009 - nature.com
Ample data indicate that mutant p53 proteins not only lose their tumour suppressive
functions, but also gain new abilities that promote tumorigenesis. Moreover, recent studies …

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary

AA Ahmed, D Etemadmoghadam… - The Journal of …, 2010 - Wiley Online Library
Numerous studies have tested the association between TP53 mutations in ovarian cancer
and prognosis but these have been consistently confounded by limitations in study design …

Mutant p53 gain-of-function in cancer

M Oren, V Rotter - Cold Spring Harbor perspectives in …, 2010 - cshperspectives.cshlp.org
In its wild-type form, p53 is a major tumor suppressor whose function is critical for protection
against cancer. Many human tumors carry missense mutations in the TP53 gene, encoding …

Personalized characterization of diseases using sample-specific networks

X Liu, Y Wang, H Ji, K Aihara, L Chen - Nucleic acids research, 2016 - academic.oup.com
A complex disease generally results not from malfunction of individual molecules but from
dysfunction of the relevant system or network, which dynamically changes with time and …

[HTML][HTML] PTEN tumor-suppressor: the dam of stemness in cancer

F Luongo, F Colonna, F Calapà, S Vitale, ME Fiori… - Cancers, 2019 - mdpi.com
PTEN is one of the most frequently inactivated tumor suppressor genes in cancer. Loss or
variation in PTEN gene/protein levels is commonly observed in a broad spectrum of human …

MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes

Y Li, F Guessous, Y Zhang, C DiPierro, B Kefas… - Cancer research, 2009 - AACR
Abstract MicroRNA-34a (miR-34a) is a transcriptional target of p53 that is down-regulated in
some cancer cell lines. We studied the expression, targets, and functional effects of miR-34a …

Therapeutic targeting of cancers with loss of PTEN function

LM Dillon, TW Miller - Current drug targets, 2014 - ingentaconnect.com
Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) is one of the most
frequently disrupted tumor suppressors in cancer. The lipid phosphatase activity of PTEN …

Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion

SE Golding, E Rosenberg, N Valerie, I Hussaini… - Molecular cancer …, 2009 - AACR
Ataxia telangiectasia (AT) mutated (ATM) is critical for cell cycle checkpoints and DNA
repair. Thus, specific small molecule inhibitors targeting ATM could perhaps be developed …

microRNA-34a is tumor suppressive in brain tumors and glioma stem cells

F Guessous, Y Zhang, A Kofman, A Catania, Y Li… - Cell cycle, 2010 - Taylor & Francis
We recently found that microRNA-34a (miR-34a) is downregulated in human glioma tumors
as compared to normal brain, and that miR-34a levels in mutant-p53 gliomas were lower …